Toward a Precision Approach in Managing Acute Respiratory Failure in the Immunocompromised Patient.
No abstract available
COI Statement
Dr. Lawler is supported by the Fonds de Recherche du Quebec. The remaining authors have disclosed that they do not have any potential conflicts of interest.
References:
Azoulay E, Mokart D, Lambert J, et al.: Diagnostic strategy for hematology and oncology patients with acute respiratory failure: Randomized controlled trial. Am J Respir Crit Care Med 2013; 187:1036–1044
Azoulay E, Mokart D, Kouatchet A, et al.: Acute respiratory failure in immunocompromised adults. Lancet Resp Med 2019; 7:173–186
Frat JP, Thille AW, Mercat A, et al.; FLORALI Study Group: High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372:2185–2196
Patel BK, Wolfe KS, Pohlman AS, et al.: Effect of noninvasive ventilation vs. high-flow nasal cannula oxygen therapy on intubation rates in patients with acute hypoxemic respiratory failure: A randomized clinical trial. JAMA 2016; 315:2435–2441
Ferreyro BL, Angriman F, Munshi L, et al.: Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: A systematic review and meta-analysis. JAMA 2020; 324:57–67